Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34


Targeting Non-Genomic Activity of Retinoic Acid Receptor-Gamma by Acacetin.

Liu J, Huang JG, Zeng JZ.

Methods Mol Biol. 2019;2019:15-31. doi: 10.1007/978-1-4939-9585-1_2.


Chemical Structures and Pharmacological Profiles of Ginseng Saponins.

Shi ZY, Zeng JZ, Wong AST.

Molecules. 2019 Jul 3;24(13). pii: E2443. doi: 10.3390/molecules24132443. Review.


Sialyl Lewisx-P-selectin cascade mediates tumor-mesothelial adhesion in ascitic fluid shear flow.

Li SS, Ip CKM, Tang MYH, Tang MKS, Tong Y, Zhang J, Hassan AA, Mak ASC, Yung S, Chan TM, Ip PP, Lee CL, Chiu PCN, Lee LTO, Lai HC, Zeng JZ, Shum HC, Wong AST.

Nat Commun. 2019 Jun 3;10(1):2406. doi: 10.1038/s41467-019-10334-6.


Targeting to the non-genomic activity of retinoic acid receptor-gamma by acacetin in hepatocellular carcinoma.

Zeng W, Zhang C, Cheng H, Wu YL, Liu J, Chen Z, Huang JG, Ericksen RE, Chen L, Zhang H, Wong AS, Zhang XK, Han W, Zeng JZ.

Sci Rep. 2017 Mar 23;7(1):348. doi: 10.1038/s41598-017-00233-5.


TRC4, an improved triptolide derivative, specifically targets to truncated form of retinoid X receptor-alpha in cancer cells.

Wang PY, Zeng WJ, Liu J, Wu YL, Ma Y, Zeng Z, Pang JY, Zhang XK, Yan X, Wong AST, Zeng JZ.

Biochem Pharmacol. 2017 Jan 15;124:19-28. doi: 10.1016/j.bcp.2016.10.014. Epub 2016 Oct 31.


Novel N-Substituted 2-(2-(Adamantan-1-yl)-1H-Indol-3-yl)-2-Oxoacetamide Derivatives: Synthesis and Biological Evaluation.

Hu HY, Yu XD, Wang F, Lin CR, Zeng JZ, Qiu YK, Fang MJ, Wu Z.

Molecules. 2016 May 5;21(5). pii: E530. doi: 10.3390/molecules21050530.


[Chemical constituents and cytotoxicity assay research in small polar substances from Vitis thunbergii var. taiwaniana].

Jiang C, Wang WZ, Liao XJ, Zeng DQ, Ling T, Xu SL, Zeng JZ, Chen HF.

Zhongguo Zhong Yao Za Zhi. 2015 Aug;40(15):2999-3004. Chinese.


Quantification of protein copy number in single mitochondria: The Bcl-2 family proteins.

Chen C, Zhang X, Zhang S, Zhu S, Xu J, Zheng Y, Han J, Zeng JZ, Yan X.

Biosens Bioelectron. 2015 Dec 15;74:476-82. doi: 10.1016/j.bios.2015.06.057. Epub 2015 Jul 3.


Identification of mitochondria-targeting anticancer compounds by an in vitro strategy.

Zhang X, Zhang S, Zhu S, Chen S, Han J, Gao K, Zeng JZ, Yan X.

Anal Chem. 2014 Jun 3;86(11):5232-7. doi: 10.1021/ac500918g. Epub 2014 May 21.


Retinoid X receptor agonists inhibit hypertension-induced myocardial hypertrophy by modulating LKB1/AMPK/p70S6K signaling pathway.

Zhu J, Ning RB, Lin XY, Chai DJ, Xu CS, Xie H, Zeng JZ, Lin JX.

Am J Hypertens. 2014 Aug;27(8):1112-24. doi: 10.1093/ajh/hpu017. Epub 2014 Mar 6.


Regulation of proteolytic cleavage of retinoid X receptor-α by GSK-3β.

Gao W, Liu J, Hu M, Huang M, Cai S, Zeng Z, Lin B, Cao X, Chen J, Zeng JZ, Zhou H, Zhang XK.

Carcinogenesis. 2013 Jun;34(6):1208-15. doi: 10.1093/carcin/bgt043. Epub 2013 Feb 6.


Targeting truncated retinoid X receptor-α by CF31 induces TNF-α-dependent apoptosis.

Wang GH, Jiang FQ, Duan YH, Zeng ZP, Chen F, Dai Y, Chen JB, Liu JX, Liu J, Zhou H, Chen HF, Zeng JZ, Su Y, Yao XS, Zhang XK.

Cancer Res. 2013 Jan 1;73(1):307-18. doi: 10.1158/0008-5472.CAN-12-2038. Epub 2012 Nov 14.


High-throughput multiparameter analysis of individual mitochondria.

Zhang S, Zhu S, Yang L, Zheng Y, Gao M, Wang S, Zeng JZ, Yan X.

Anal Chem. 2012 Aug 7;84(15):6421-8. doi: 10.1021/ac301464x. Epub 2012 Jul 19.


Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.

Lu N, Liu J, Liu J, Zhang C, Jiang F, Wu H, Chen L, Zeng W, Cao X, Yan T, Wang G, Zhou H, Lin B, Yan X, Zhang XK, Zeng JZ.

PLoS One. 2012;7(4):e35722. doi: 10.1371/journal.pone.0035722. Epub 2012 Apr 24.


Nur77: a potential therapeutic target in cancer.

To SK, Zeng JZ, Wong AS.

Expert Opin Ther Targets. 2012 Jun;16(6):573-85. doi: 10.1517/14728222.2012.680958. Epub 2012 Apr 26. Review.


Structural modification of ginsenoside Rh(2) by fatty acid esterification and its detoxification property in antitumor.

Wei GQ, Zheng YN, Li W, Liu WC, Lin T, Zhang WY, Chen HF, Zeng JZ, Zhang XK, Chen QC.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):1082-5. doi: 10.1016/j.bmcl.2011.11.104. Epub 2011 Dec 7.


Regulation of Nur77 expression by β-catenin and its mitogenic effect in colon cancer cells.

Wu H, Lin Y, Li W, Sun Z, Gao W, Zhang H, Xie L, Jiang F, Qin B, Yan T, Chen L, Zhao Y, Cao X, Wu Y, Lin B, Zhou H, Wong AS, Zhang XK, Zeng JZ.

FASEB J. 2011 Jan;25(1):192-205. doi: 10.1096/fj.10-166462. Epub 2010 Sep 16.


NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.

Zhou H, Liu W, Su Y, Wei Z, Liu J, Kolluri SK, Wu H, Cao Y, Chen J, Wu Y, Yan T, Cao X, Gao W, Molotkov A, Jiang F, Li WG, Lin B, Zhang HP, Yu J, Luo SP, Zeng JZ, Duester G, Huang PQ, Zhang XK.

Cancer Cell. 2010 Jun 15;17(6):560-73. doi: 10.1016/j.ccr.2010.04.023.


Oncogenic potential of retinoic acid receptor-gamma in hepatocellular carcinoma.

Yan TD, Wu H, Zhang HP, Lu N, Ye P, Yu FH, Zhou H, Li WG, Cao X, Lin YY, He JY, Gao WW, Zhao Y, Xie L, Chen JB, Zhang XK, Zeng JZ.

Cancer Res. 2010 Mar 15;70(6):2285-95. doi: 10.1158/0008-5472.CAN-09-2968. Epub 2010 Mar 2.


Retinoid X receptor agonists inhibit phorbol-12-myristate-13-acetate (PMA)-induced differentiation of monocytic THP-1 cells into macrophages.

Zhou L, Shen LH, Hu LH, Ge H, Pu J, Chai DJ, Shao Q, Wang L, Zeng JZ, He B.

Mol Cell Biochem. 2010 Feb;335(1-2):283-9. doi: 10.1007/s11010-009-0278-z. Epub 2009 Sep 27.


Supplemental Content

Loading ...
Support Center